KYLE CLIFTON, Senior Director, Market Access & Commercialization Services (MACS), Red Nucleus

Kyle has over 15 years’ experience in the life sciences industry with expertise in commercial and market access strategies, access planning, and value communication. At Red Nucleus, he has robust experience in assessing value, setting price, and developing innovative contracts, with specific focus on therapies for rare diseases and oncology. He has also focused on payer strategy, evidence generation, patient and provider access, and reimbursement strategies across settings of care